{"id":"W2139560421","doi":"10.1016/s1474-4422(14)70222-4","title":"Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Ceftriaxone; Placebo; Medicine; Amyotrophic lateral sclerosis; Internal medicine; Clinical trial; Antibiotics; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003089394,0.002550125,0.006668015,0.0007226208,0.0006448511,0.001523862,0.001357028,0.005126936,0.006055424],"category_scores_gemma":[0.004874217,0.001085607,0.003495523,0.0005951781,0.002198675,0.002075151,0.0005283804,0.003123949,0.001234704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001060308,"about_ca_system_score_gemma":0.00115531,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001082473,"about_ca_topic_score_gemma":0.001373159,"domain_scores_codex":[0.9982269,0.0008659814,0.0001857436,0.0003604743,0.0001486905,0.0002121527],"domain_scores_gemma":[0.9976414,0.001021495,0.0005229336,0.0001954908,0.0002002491,0.0004183464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9934324,0.0009957313,0.000161349,0.0005975317,0.0005340789,0.00001933117,0.00002322255,0.00005917386,0.0009407919,0.00003550965,0.0001498628,0.003050968],"study_design_scores_gemma":[0.9812384,0.01727555,0.0006042948,0.00003706282,0.0003571909,0.00001234097,0.000008565569,0.0001095547,0.0001248396,0.00004969696,0.0001712301,0.00001124981],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9678479,0.01815585,0.001506221,0.001136284,0.001592044,0.006254595,0.001302796,0.0001584449,0.002045705],"genre_scores_gemma":[0.9780436,0.006475832,0.001911924,0.001378555,0.0009920815,0.006658717,0.001020133,0.00003344123,0.003485695],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006668015,"threshold_uncertainty_score":0.02025735,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1202433911599397,"score_gpt":0.3510640716441955,"score_spread":0.2308206804842557,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}